Evaluation of the quality of radiotherapy randomized trials for painful bone metastases : Implications for future research design and reporting

Quality of life, mucositis, and xerostom

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

✍ Graeme G. Duncan; Joel B. Epstein; Dongsheng Tu; Samy El Sayed; Andrea Bezjak; J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## Background. The National Cancer Institute of Canada Clinical Trials Group undertook a multicenter, randomized, double‐blind controlled trial of an oral antimicrobial versus placebo to prevent and treat mucositis. We present the quality of life (QOL) analysis for this trial. ## Meth